2024-04-01 16:05 | UU:SIGA | | News Release200 | SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX(TM) |
2024-03-25 07:30 | UU:SIGA | | News Release200 | SIGA Names Larry Miller General Counsel |
2024-03-12 16:05 | UU:SIGA | | News Release200 | SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023 |
2024-03-12 07:30 | UU:SIGA | | News Release200 | SIGA Declares Special Cash Dividend of $0.60 Per Share |
2024-03-05 07:30 | UU:SIGA | | News Release200 | SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results |
2024-01-22 07:30 | UU:SIGA | | News Release200 | SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer |
2023-11-07 16:05 | UU:SIGA | | News Release200 | SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023 |
2023-10-26 07:30 | UU:SIGA | | News Release200 | SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results |
2023-10-23 08:00 | UU:SIGA | | News Release200 | SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX ‚ ® (Tecovirimat) by Participating Countries |
2023-09-06 07:30 | UU:SIGA | | News Release200 | SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer |
2023-08-08 16:05 | UU:SIGA | | News Release200 | SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023 |
2023-07-27 16:45 | UU:SIGA | | News Release200 | SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX ‚ ® |
2023-07-27 07:30 | UU:SIGA | | News Release200 | SIGA Technologies to Host Business Update Call on Tuesday, August 8th, 2023 Following Release of Second Quarter 2023 Financial Results |
2023-06-27 16:05 | UU:SIGA | | News Release200 | SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium |
2023-05-04 16:05 | UU:SIGA | | News Release200 | SIGA Reports Financial Results for Three Months Ended March 31, 2023 |
2023-05-04 07:30 | UU:SIGA | | News Release200 | SIGA Declares Special Cash Dividend of $0.45 Per Share |
2023-04-27 07:30 | UU:SIGA | | News Release200 | SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results |